Refresh

Aarti Drugs Ltd. - Research Center

524348 AARTIDRUGS Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

2,497.97 2,251.17 1,914.89 1,634.92 1,454.25
Expenses

Material consumed

1,775.86 1,529.31 1,180.83 1,081.35 994.54

Manufacturing expenses

286.45 258.43 203.41 197.71 166.00

Personnel expenses

74.99 69.32 69.29 60.10 53.14

Selling expenses

0.35 0.35 0.27 0.70 1.40

Adminstrative expenses

77.91 75.58 59.82 50.66 39.89

Expenses capitalised

- - - - -

Cost of sales

2,215.57 1,932.99 1,513.62 1,390.51 1,254.96

Operating profit

282.40 318.18 401.27 244.41 199.30

Other recurring income

2.23 4.77 6.42 1.06 2.51

Adjusted PBDIT

284.64 322.96 407.69 245.47 201.81

Financial expenses

32.53 20.07 22.61 32.20 37.56

Depreciation

47.29 47.39 47.60 46.67 40.39

Other write offs

- - - - -

Adjusted PBT

204.81 255.50 337.49 166.60 123.86

Tax charges

52.00 60.50 80.00 39.30 40.37

Adjusted PAT

152.81 195.00 257.49 127.30 83.49

Non recurring items

- - 0.22 8.38 3.77

Other non cash adjustments

- - - - -

Reported net profit

152.81 195.00 257.71 135.67 87.26

Earnigs before appropriation

971.67 899.26 823.23 610.75 486.62

Equity dividend

9.26 9.26 23.30 5.55 1.87

Preference dividend

- - - - -

Dividend tax

- - - 1.44 0.48

Retained earnings

962.41 890.00 799.93 603.76 484.26
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com